Mayo Clinic physician Timothy Curry and genomics scientist Matthew Ferber paired up to set the stage for the Individualizing Medicine 2014 Conference with opening remarks at the pre-conference session, an “Introduction to Genomic Medicine for Practitioners.” They detailed how genomic medicine is now making the transition from technological marvel to bedside practice for physicians.
“Genomics isn’t just the future,” Dr. Curry said. “Genomics is now.”
Over 150 people attended this introductory conference for practitioners, a preliminary session to Mayo Clinic’s third annual conference on genomic medicine. The international audience received a tutorial in the fundamentals of genetic principles and were offered a primer on how genomics is making the rapid transition from promise to practice.
Three case studies—in oncology, pharmacogenomics, and diagnostics—detailed the physician’s odyssey in applying genomics to day-to-day practice. Physicians, genetic counselors, pharmacists, and bioethicists provided attendees with insights and first-hand patient stories on how the science of genomics is being applied to clinical practices. The three case studies demonstrated how practitioners are using genomic medicine to improve the quality of treatment for patients.
“This is truly a team approach to medicine,” Dr. Curry said. “It is how we are bringing individualized medicine to the patients.”
The 2014 Individualized Medicine Conference begins tomorrow, October 6, and promises to be an informative and exciting look at the present and future of genomic medicine. If you’re unable to attend, follow along on Twitter at #CIMcon14.